AU745209B2 - Methods for quenching pathogen inactivators in biological materials - Google Patents

Methods for quenching pathogen inactivators in biological materials Download PDF

Info

Publication number
AU745209B2
AU745209B2 AU82891/98A AU8289198A AU745209B2 AU 745209 B2 AU745209 B2 AU 745209B2 AU 82891/98 A AU82891/98 A AU 82891/98A AU 8289198 A AU8289198 A AU 8289198A AU 745209 B2 AU745209 B2 AU 745209B2
Authority
AU
Australia
Prior art keywords
pathogen
quencher
group
inactivating compound
pathogen inactivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82891/98A
Other languages
English (en)
Other versions
AU8289198A (en
Inventor
David Cook
Adonis Stassinopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of AU8289198A publication Critical patent/AU8289198A/en
Application granted granted Critical
Publication of AU745209B2 publication Critical patent/AU745209B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
AU82891/98A 1998-01-06 1998-07-06 Methods for quenching pathogen inactivators in biological materials Ceased AU745209B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7059798P 1998-01-06 1998-01-06
US60/070597 1998-01-06
PCT/US1998/013931 WO1999034839A1 (en) 1998-01-06 1998-07-06 Methods for quenching pathogen inactivators in biological materials

Publications (2)

Publication Number Publication Date
AU8289198A AU8289198A (en) 1999-07-26
AU745209B2 true AU745209B2 (en) 2002-03-14

Family

ID=22096274

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82891/98A Ceased AU745209B2 (en) 1998-01-06 1998-07-06 Methods for quenching pathogen inactivators in biological materials

Country Status (11)

Country Link
US (3) US6270952B1 (US06270952-20010807-C00001.png)
EP (1) EP1045704B1 (US06270952-20010807-C00001.png)
JP (2) JP4643004B2 (US06270952-20010807-C00001.png)
CN (1) CN1203900C (US06270952-20010807-C00001.png)
AT (1) ATE276771T1 (US06270952-20010807-C00001.png)
AU (1) AU745209B2 (US06270952-20010807-C00001.png)
CA (1) CA2317603A1 (US06270952-20010807-C00001.png)
DE (1) DE69826521T2 (US06270952-20010807-C00001.png)
ES (1) ES2224415T3 (US06270952-20010807-C00001.png)
HK (1) HK1034682A1 (US06270952-20010807-C00001.png)
WO (1) WO1999034839A1 (US06270952-20010807-C00001.png)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
AU745209B2 (en) * 1998-01-06 2002-03-14 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US6369048B1 (en) 1998-01-12 2002-04-09 V.I. Technologies, Inc. Methods and compositions for inactivating viruses
US20030073650A1 (en) * 1998-07-21 2003-04-17 Heather Reddy Method and apparatus for inactivation of biological contaminants using photosensitizers
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
AU2001266683A1 (en) * 2000-05-31 2001-12-11 Cerus Corporation Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
WO2003061379A2 (en) * 2000-12-21 2003-07-31 Cerus Corporation Methods for inactivation of pathogens in biological materials
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
US20030141260A1 (en) * 2001-12-28 2003-07-31 Frank Corbin Oxygen-enhanced pathogen inactivation
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US7235392B2 (en) * 2001-12-07 2007-06-26 The Ohio State University Research Foundation Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
EP1531823A4 (en) * 2002-05-10 2007-07-18 Univ Ohio State FLAVIN N-OXIDE: NEW CANCER AND MEANS TO REMOVE ENTANGERS
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
EP1592441B1 (en) * 2003-02-06 2012-04-11 Aduro Biotech Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
WO2004084936A2 (en) 2003-02-06 2004-10-07 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
BRPI0518198B8 (pt) 2004-10-29 2021-06-22 Cerus Corp método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit
WO2009126786A2 (en) 2008-04-09 2009-10-15 Cerus Corporation Improved quenching methods for red blood cell pathogen inactivation
EP2283112B1 (en) 2008-05-19 2016-10-12 Aduro Biotech Compositions comprising prfa*mutant listeria and methods of use thereof
WO2011008441A1 (en) * 2009-06-30 2011-01-20 3M Innovative Properties Company Light-activated antimicrobial article and method of use
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
US10842818B2 (en) 2014-07-23 2020-11-24 Cerus Corporation Methods for preparing platelet products
AU2016283389B2 (en) 2015-06-26 2022-09-15 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
EP3364986B1 (en) 2015-10-23 2023-12-13 Cerus Corporation Pathogen-inactivated cryo-poor plasma and methods of use thereof
JP2020503512A (ja) 2016-12-23 2020-01-30 シーラス コーポレイション 化合物結合基材を使用して、試験およびスクリーニングするためのシステムおよび方法
US20190321407A1 (en) 2016-12-31 2019-10-24 Cerus Corporation Compositions and methods for preparation of red blood cells
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018395525B2 (en) * 2017-12-29 2023-09-14 Cerus Corporation Systems and methods for treating biological fluids
EA202190810A1 (ru) * 2018-09-20 2021-08-23 Сирус Корпорейшн Способы и наборы для получения цельной крови с инактивированным патогеном
CN114269394A (zh) 2019-06-28 2022-04-01 塞鲁斯公司 用于实现生物流体处理装置的系统和方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
WO1996039818A1 (en) * 1995-06-07 1996-12-19 Cerus Corporation Treating red blood cell solutions with anti-viral agents
US6159500A (en) * 1996-12-31 2000-12-12 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281579A (en) * 1883-07-17 Electric valve
US2402665A (en) 1942-11-12 1946-06-25 Du Pont Chemical process
US2402655A (en) 1943-09-22 1946-06-25 Miller Pottery Engineering Co Pottery slip-casting apparatus
IT1093275B (it) 1978-01-26 1985-07-19 Snam Progetti Composizione adatta alla purificazione del sangue e suoi impieghi
US4337269A (en) 1979-07-23 1982-06-29 Sutton Laboratories, Inc. Preservative compositions
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5281579A (en) 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
US4971760A (en) 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en) 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5055485A (en) 1988-12-02 1991-10-08 New York Blood Center, Inc. Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5753258A (en) 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
GB9218581D0 (en) 1992-09-02 1992-10-14 Pall Corp Removal of unwanted fluids from processed blood products
CA2165065A1 (en) 1993-06-23 1995-01-05 Henrietta Margolis-Nunno System for viral inactivation of blood
US5591350A (en) 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
SE9402472L (sv) * 1994-07-13 1996-01-14 Forskarpatent I Linkoeping Ab Modifierade ytor
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5660731A (en) 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US5637451A (en) 1995-03-29 1997-06-10 New York Blood Center, Inc. Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
DE69638094D1 (de) 1995-06-07 2010-01-21 Cerus Corp Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
AU703108B2 (en) * 1995-06-07 1999-03-18 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
WO1997002028A1 (en) 1995-06-29 1997-01-23 Hemasure, Inc. Inactivation of pathogens using hydroxymethylamines
US6114108A (en) 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
US6136586A (en) 1995-08-29 2000-10-24 Vi Technologies, Inc. Methods for the selective modification of viral nucleic acids
EP0881874B1 (en) 1995-11-06 2003-04-02 New York Blood Center, Inc. Viral inactivation treatment of red blood cells using phthalocyanines and red light
AU1085697A (en) 1995-11-21 1997-06-11 Pall Corporation Inactivation method and system in biological fluids
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
CN101676268B (zh) * 1997-01-06 2013-09-25 塞鲁斯公司 用于病原体灭活的脆性化合物
AU745209B2 (en) * 1998-01-06 2002-03-14 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US6150109A (en) 1999-01-25 2000-11-21 V. I. TECHNOLOGIES, Inc. Lipophilic quenching of viral inactivating agents
BRPI0518198B8 (pt) 2004-10-29 2021-06-22 Cerus Corp método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
WO1996039818A1 (en) * 1995-06-07 1996-12-19 Cerus Corporation Treating red blood cell solutions with anti-viral agents
US6159500A (en) * 1996-12-31 2000-12-12 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof

Also Published As

Publication number Publication date
US20040180321A1 (en) 2004-09-16
CN1284886A (zh) 2001-02-21
ES2224415T3 (es) 2005-03-01
US6709810B2 (en) 2004-03-23
US7293985B2 (en) 2007-11-13
CA2317603A1 (en) 1999-07-15
EP1045704A1 (en) 2000-10-25
DE69826521T2 (de) 2005-09-29
US6270952B1 (en) 2001-08-07
DE69826521D1 (de) 2004-10-28
AU8289198A (en) 1999-07-26
ATE276771T1 (de) 2004-10-15
US20020028432A1 (en) 2002-03-07
JP4643004B2 (ja) 2011-03-02
JP2010248245A (ja) 2010-11-04
WO1999034839A1 (en) 1999-07-15
CN1203900C (zh) 2005-06-01
HK1034682A1 (en) 2001-11-02
JP2002500204A (ja) 2002-01-08
EP1045704B1 (en) 2004-09-22

Similar Documents

Publication Publication Date Title
AU745209B2 (en) Methods for quenching pathogen inactivators in biological materials
US5712086A (en) Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions
US6548242B2 (en) Process for the sterilization of biological compositions and the product thereby
US6214534B1 (en) Biological compositions containing quenchers of type I and type II photodynamic reactions
CA2203885C (en) Treating red blood cell solutions with anti-viral agents
AU722811B2 (en) Treating red blood cell solutions with anti-viral agents
AU740547B2 (en) Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
US6177441B1 (en) Treating red blood cell solutions with anti-viral agents
EP0702719B1 (en) Process for the sterilization of biological compositions and the product produced thereby
JPH04226919A (ja) 細胞含有組成物中のウイルスの光力学的不活性化
CA2165065A1 (en) System for viral inactivation of blood
US20030113704A1 (en) Methods for inactivation of pathogens in biological materials
AU7153800A (en) Treating red blood cell solutions with anti-viral agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)